By identifying thousands of SMAD4 binding loci as well as regulated genes, our data provide both a new resource for studying the mechanism underlying dysregulated TGFβ signaling in ovarian cancer cells as well as potential prognostic biomarkers for future ovarian cancer translational research. This evidence concerns the gene TGFB1 and ovarian carcinoma.